Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus

Clinical trial NCT00290979 · COMPLETED

Trial details

NCT number: NCT00290979
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2004-12-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.